NINKOVIC, Sacha,CROSIGNANI, Stefano,SCALES, Stephanie Anne,MCALPINE, Indrawan James,COLLINS, Michael Raymond,MADERNA, Andreas,WYTHES, Martin
申请号：
SG11201706992T
公开号：
SG11201706992TA
申请日:
2016.03.17
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
or pharmaceutically acceptable enantiomers, salts or solvates thereof. The invention further relates to the use of the compounds of Formula I as TDO2 inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer, neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression, and obesity. The invention also relates to a process for manufacturing compounds of Formula I.
